Race/Ethnic Differences in the Risk of Hemorrhagic Complications Among Patients With Ischemic Stroke Receiving Thrombolytic Therapy-Reference-Cited by-同舟云学术

Race/Ethnic Differences in the Risk of Hemorrhagic Complications Among Patients With Ischemic Stroke Receiving Thrombolytic Therapy

Published:2014-08 Issue:8 Volume:45 Page:2263-2269
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Mehta Rajendra H.¹,Cox Margueritte¹,Smith Eric E.¹,Xian Ying¹,Bhatt Deepak L.¹,Fonarow Gregg C.¹,Peterson Eric D.¹

Affiliation:

1. From the Department of Internal Medicine/Division of Cardiology, Duke University Medical Center and Duke Clinical Research Institute, Durham, NC (R.H.M., M.C., Y.X., E.D.P.); Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada (E.E.S.); Department of Internal Medicine/Division of Cardiology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA (D.L.B.); and Department of Internal Medicine/Division of Cardiology, University of California, Los Angeles (G.C.F.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

Reference20 articles.

1. Tissue Plasminogen Activator for Acute Ischemic Stroke

2. Intravenous Thrombolysis With Recombinant Tissue Plasminogen Activator for Acute Hemispheric Stroke

3. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)

4. Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset

5. Early stroke treatment associated with better outcome: The NINDS rt-PA Stroke Study

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Race, Ethnicity, and Gender Disparities in the Management and Outcomes of Critically Ill Adults with Acute Stroke;Critical Care Clinics;2024-10

2. Racial disparities in access to, and outcomes of, acute ischaemic stroke treatments in the USA;Stroke and Vascular Neurology;2024-05-21

3. Discovery of 2,3-Dihydro[1,4]dioxino[2,3-g]benzofuran Derivatives as Protease Activated Receptor 4 (PAR4) Antagonists with Potent Antiplatelet Aggregation Activity and Low Bleeding Tendency;Journal of Medicinal Chemistry;2024-03-29

4. Efficacy and safety outcomes of Tenecteplase versus Alteplase for thrombolysis of acute ischemic stroke: A meta-analysis of 9 randomized controlled trials;Journal of the Neurological Sciences;2024-03

5. Trends in Stroke Thrombolysis Care Metrics and Outcomes by Race and Ethnicity, 2003-2021;JAMA Network Open;2024-02-07